Laboratory-acquired vaccinia infection

被引:14
作者
Wlodaver, CG
Palumbo, GJ
Waner, JL
机构
[1] Univ Oklahoma, Childrens Hosp, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA
关键词
vaccinia virus; laboratory acquired infection; generalized vaccinia;
D O I
10.1016/S1386-6532(03)00118-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Complications following vaccination with vaccinia virus have been well described but are not commonly observed. The use of vaccinia as a tool in molecular biology, in the development of therapeutics, and the anticipated increase of vaccinations in the general population due to the threat of bioterrorism have created a renewed awareness of the post-vaccination complications and the consequent need for clinical and laboratory diagnosis. Objectives: To report the clinical presentation and subsequent diagnosis of generalized vaccinia that resulted from a laboratory accident in an unvaccinated subject. Study design: The patient was seen by a local infectious disease's specialist and evaluated clinically and with laboratory support relative to a differential diagnosis. Results: Careful assessment of the patient's history, an evaluation of the workplace, and the elimination of likely microbial etiologies led to the diagnosis of generalized vaccinia. Laboratory confirmation was obtained by use of electron microscopy (EM) to observe poxvirus particles in infected cell cultures. Conclusions: Exposure to vaccinia virus should raise the index of suspicion for patients with skin lesions. Rapid diagnosis may be accomplished by direct examination of lesion material by EM. The virus also readily replicates in commonly available cell cultures and in the absence of immune reagents, typical poxvirus particles may be observed in the infected cells by EM. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 15 条
[1]  
BINNS MM, 1992, RECOMBINANT POXVIRUS, P235
[2]  
BULLER RML, 1992, RECOMBINANT POXVIRUS, P235
[3]   COWPOX IN A CHILD, ACQUIRED FROM A CAT [J].
CASEMORE, DP ;
EMSLIE, ES ;
WHYLER, DK ;
BAXBY, D ;
BENNETT, M ;
DAVIES, AB .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (04) :286-287
[4]  
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1
[5]   Smallpox as a biological weapon - Medical and public health management [J].
Henderson, DA ;
Inglesby, TV ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Jahrling, PB ;
Hauer, J ;
Layton, M ;
McDade, J ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, T ;
Russell, PK ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (22) :2127-2137
[6]   Progressive vaccinia treated with ribavirin and vaccinia immune globulin [J].
Kesson, AM ;
Ferguson, JK ;
Rawlinson, WD ;
Cunningham, AL .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (04) :911-914
[7]  
KLINGEBIEL T, 1988, PEDIATR INFECT DIS J, V7, P883, DOI 10.1097/00006454-198807120-00013
[8]   COMPLICATIONS OF SMALLPOX VACCINATION, 1968 - NATIONAL SURVEILLANCE IN UNITED STATES [J].
LANE, JM ;
RUBEN, FL ;
NEFF, JM ;
MILLAR, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 281 (22) :1201-&
[9]  
LeDuc JW, 2001, EMERG INFECT DIS, V7, P155
[10]  
Nakano JH, 1989, DIAGNOSTIC PROCEDURE, P224